Tumor
-
Risk of secondary tumors from melanoma drug studied
A new study offers clues on why melanoma patients who are treated with oral drugs inhibiting the BRAF gene are at increased risk for developing secondary skin cancers. Read MoreMar 23, 2012
-
Protein ‘scissors’ cut path for cancer
The protein matriptase "cuts" a key component of the prostate tissue barrier and may be involved in prostrate cancer progression, new research finds. Read MoreFeb 22, 2011
-
Integrin curbs cancer’s spread
Cell surface molecules called integrins have been found to play an important role when cancer metastasizes. Read MoreFeb 16, 2011